Details:
Under the terms of the agreement, FrostPharma will receive exclusive marketing rights to Sibnayal™ for the treatment of dRTA. Advicenne will receive a transfer price for the sale of its product and royalties for an amount significantly higher than 50% of future sales.
Lead Product(s): Potassium Citrate,Potassium hydrogen carbonate
Therapeutic Area: Nephrology Product Name: Sibnayal
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: FrostPharma AB
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 04, 2022
Details:
Sibnayal™ is a multi-particulate formulation in 2mm granules, a novel pioneering delivery technology created by Advicenne that contains two active pharmaceutical ingredients.
Lead Product(s): Potassium Citrate,Potassium hydrogen carbonate
Therapeutic Area: Nephrology Product Name: Sibnayal
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 02, 2021
Details:
Advicenne’s lead product, ADV7103, is developed as a multi-particulate formulation in 2mm microtablets, a novel pioneering delivery technology created by Advicenne that contains two active pharmaceutical ingredients to ease its administration.
Lead Product(s): Potassium Citrate,Potassium hydrogen carbonate
Therapeutic Area: Nephrology Product Name: Sibnayal
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 17, 2021
Details:
ADV7103/Sibnayal (potassium citrate) becomes the first and only label-approved drug for the treatment of distal renal tubular acidosis (dRTA) in adults, adolescents and children aged one year and older.
Lead Product(s): Potassium Citrate,Potassium hydrogen carbonate
Therapeutic Area: Nephrology Product Name: Sibnayal
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 03, 2021